Literature DB >> 47611

The clinical pharmacology of antineoplastic agents (second of two parts).

B A Chabner, C E Myers, C N Coleman, D G Johns.   

Abstract

Mesh：

Substances：

Year:  1975        PMID： 47611     DOI： 10.1056/NEJM197505292922206

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

1.  High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behçet's disease.

Authors:  H H Tessler; T Jennings
Journal:  Br J Ophthalmol       Date:  1990-06       Impact factor: 4.638

2.  The Radiation Stress Response: Of the People, By the People and For the People.

Authors:  C Norman Coleman
Journal:  Radiat Res       Date:  2017-01-24       Impact factor: 2.841

3.  Massive bilateral nephroblastomatosis in a 13-year-old-girl.

Authors:  E Pichler; O A Jürgenssen; E Balzar; W F Pinggera; A Wolf; O Wagner; G Reinartz; H Czembirek; G Syré
Journal:  Eur J Pediatr       Date:  1982-05       Impact factor: 3.183

4.  The effect of chronic daily cyclophosphamide administration on established antibody responses.

Authors:  R F Gagnon; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

Review 5.  Serine, glycine and one-carbon units: cancer metabolism in full circle.

Authors:  Jason W Locasale
Journal:  Nat Rev Cancer       Date:  2013-07-04       Impact factor: 60.716

6.  The protein binding of methotrexate by the serum of normal subjects.

Authors:  W H Steele; J R Lawrence; J F Stuart; C A McNeill
Journal:  Eur J Clin Pharmacol       Date:  1979-06-12       Impact factor: 2.953

7.  Cardiomyopathy in leukemia, with reference to rubidomycin cardiotoxicity.

Authors:  B Lantz; J Adolfsson; B Lagerlöf; P Reizenstein
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

8.  Growth response of B16 melanoma to in vivo treatment with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) at the initial stage after tumor transplantation.

Authors:  X H Li; G Paulus; G Atassi; N Buyssens
Journal:  Am J Pathol       Date:  1984-06       Impact factor: 4.307

9.  The potential of nucleotide analogs as inhibitors of retroviruses and tumors.

Authors:  R K Robins
Journal:  Pharm Res       Date:  1984-01       Impact factor: 4.200

Review 10.  Metabolomics in cancer research and emerging applications in clinical oncology.

Authors:  Daniel R Schmidt; Rutulkumar Patel; David G Kirsch; Caroline A Lewis; Matthew G Vander Heiden; Jason W Locasale
Journal:  CA Cancer J Clin       Date:  2021-05-13       Impact factor: 286.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.